US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,831.70

-3.5908-0.20%

Number of Gainers:2

Number of Losers:17

Number of Flat:- -

PE:- -

High:1,844.83

Open:1,843.77

Low:1,825.88

Close:1,835.29

Volume:94.13M

Turnover:5.53B

Market Cap:1.49T

Float Cap:1.46T

Loading ...

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

iBio CEO Joins Wells Fargo Annual Healthcare Conference Fireside Chat

Inovio to Present at Cantor Global Healthcare Conference Fireside Chat

Novavax call volume above normal and directionally bullish

Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli

Simply Wall St.

Co-Diagnostics Ships Vector Smart Mosquito Surveillance Equipment to Overseas US Air Force Base

Lakeland Fire + Safety to Attend September Investor Conferences

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Ocugen Doses First Patient in Trial of Potential Eye Disease Drug

MT Newswires Live

AstraZeneca completes global license agreement for Zegfrovy in lung cancer

Ocugen - Bla Filing for Ocu410 Anticipated in 2028

THOMSON REUTERS

Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of Ocu410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

THOMSON REUTERS

Aethlon Medical Announces Annual Shareholder Meeting

AstraZeneca Reports 'Meaningful Improvement' in Phase 3 Study of Lung Cancer Patients

MT Newswires Live

AstraZeneca Says Breast Cancer Combo Approved in EU; Completes Acquisition of License for Lung Cancer Treatment

MT Newswires Live

Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks

American Tungsten & Antimony Taps Finland Firm for Scoping Study; Shares Up 4%

MT Newswires Live

Did Targeted XFG COVID Shots Just Recenter Pfizer's (PFE) Post‑Pandemic Investment Narrative?

Simply Wall St.

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared to Competitors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BK4568/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1831.6982,"timestamp":1789070399999,"preClose":1835.2891,"halted":0,"volume":94127665,"delay":0,"changeRate":-0.001957,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-3.59082,"latestTime":"09-10 16:00:00 EDT","open":1843.7695,"high":1844.8345,"low":1825.875,"amount":5530296282.364558,"amplitude":0.010331,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.79124,"peRate":46.664448,"turnoverRate":0.006785,"increases":2,"decrements":17,"flats":0,"marketCap":1489973728402,"floatMarketCap":1456164959030},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1844.8345,"amplitude":0.010331,"preClose":1835.2891,"low":1825.875,"pbRate":"4.79124","latestPrice":1831.6982,"volume":94127665,"delay":0,"open":1843.7695,"prevYearClose":1637.1339,"prevWeekClose":1896.2245,"prevMonthClose":1860.7577,"prevQuarterClose":1731.2963,"fiveDayClose":1903.6779,"twentyDayClose":1769.2863,"sixtyDayClose":1652.1289,"secType":"PLATE","market":"US","turnoverRate":0.006785,"peRate":46.664448,"marketCap":1489973728402,"floatMarketCap":1456164959030,"timestamp":1789070399999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":2,"down":17,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664901869","title":"Moderna Inc. Stock Advances 9.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2664901869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664901869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:33","pubTimestamp":1788294780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 9.9% to $154.27 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,099.77 and Dow Jones Industrial Average falling 0.8% to 52,766.88.This was the stock's second consecutive day of gains.Moderna Inc. closed 12.7% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 2.0% to $271.19, Pfizer Inc. rose 0.3% to $28.55, and Gilead Sciences Inc. rose 2.45% to $149.92.Trading volume totaled 25.3 million, compared to the 50-day average of 16.8 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4534","LU0823416689.USD","IBBQ","LU2324357040.USD","BK4566","BK4568","BK4551","BBH","BK4588","LU0965509010.AUD","LU1934455863.HKD","LU0058720904.USD","LU2089984988.USD","SG9999015945.SGD","BMED","LU0965508806.USD","LU0861579265.USD","BK4583","TMED","IDNA","LU1057294990.SGD","LU2468319806.SGD","LU0289739699.SGD","LU1430594728.SGD","BK4501","BIB","IE00B7SZLL34.SGD","WDNA","GILD","LU1037948541.HKD","LU1066053197.SGD","TBXU","LU1934455277.USD","IBB","LU0109394709.USD","LU1934455194.USD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","MEDI","MRNY","LU2112291526.USD","LU0320765992.SGD","GNOM","LU1571399168.USD","BK4533","MRNX","BK4139","LU0234570918.USD","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664680869","title":"iBio CEO Joins Wells Fargo Annual Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664680869","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664680869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:30","pubTimestamp":1788294652,"startTime":"0","endTime":"0","summary":"iBio CEO joins Wells Fargo Annual Healthcare Conference fireside chatiBio will attend the Wells Fargo 21st Annual Healthcare Conference in Boston on Sept. 8-10, 2026.CEO Martin Brenner will join a fir","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL7TVsbc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014039.USD","LU2210150020.SGD","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014013.SGD","BK4139","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4568","BK4585","IE00BQXX3C00.GBP","BCDF","IBIO","BK4588","LU2095319765.USD","SG9999014021.USD","SG9999014005.SGD","IE00BN0W2W23.USD","BK4112","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664866473","title":"Inovio to Present at Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664866473","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664866473?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:06","pubTimestamp":1788293187,"startTime":"0","endTime":"0","summary":"Inovio to present at Cantor Global Healthcare Conference fireside chatInovio will take part in the Cantor Global Healthcare Conference in New York on September 9, including a 3:20 p.m. ET fireside cha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL3Wq6HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4583","BK4139","INO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664577568","title":"Novavax call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2664577568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664577568?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:45","pubTimestamp":1788273910,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Novavax (NVAX) with 3,284 calls trading, 1.3x expected, and implied vol increasing over 4 points to 76.04%. Sep-26 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novavax-call-volume-above-normal-and-directionally-bullish-thefly-news-6?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novavax-call-volume-above-normal-and-directionally-bullish-thefly-news-6?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4568","BK4585","BK4547","BK4588","NVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886818","title":"Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886818","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886818?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:26","pubTimestamp":1788272814,"startTime":"0","endTime":"0","summary":"Johnson & Johnson stock has delivered a 3 year total return of 80.4%, yet the latest valuation checks send mixed signals, with the Discounted Cash Flow (DCF) intrinsic value pointing to upside while market based multiples suggest the shares are not cheap.\n\nThe 80.4% gain over the past 3 years points to strong shareholder rewards that may already reflect a lot of optimism in Johnson & Johnson.\nRecent approvals for TECVAYLI in Europe and IMAAVY in the US can support long term cash flow...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/139677-main-header/1756253951625","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/139677-main-header/1756253951625"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-jnj/johnson-johnson/news/johnson-johnson-jnj-stock-may-trade-at-a-discount-as-europe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-jnj/johnson-johnson/news/johnson-johnson-jnj-stock-may-trade-at-a-discount-as-europe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1929549753.HKD","IE00BFXG1179.USD","VHT","LU0426412945.USD","BMED","IE000WAW04H5.SGD","BK4568","PJP","LU0792757196.USD","IHE","LU1718418525.SGD","LU0162691827.USD","RGLO","FHLC","LU0203345920.USD","JOYT","LU2602419157.SGD","BK4007","VOTE","LU0345769128.USD","LU0820561909.HKD","XLV","IE00B2B36J28.USD","SGXZ57979304.SGD","FEBU","LU0882574055.USD","TRUH","LU1894683264.USD","SPHQ","JNJ","BK4532","MEDX","BK4504","GXDW","IE00BJJMRZ35.SGD","LU1989771016.USD","RXL","LU1291159041.SGD","GDOC","LU2236285917.USD","JDOC","DCF","PMDE","DECU","LU1935042991.SGD","FTXH","IE00BLSP4239.USD","VGFPF","IXJ","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854655","title":"Co-Diagnostics Ships Vector Smart Mosquito Surveillance Equipment to Overseas US Air Force Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854655","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854655?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:30","pubTimestamp":1788269451,"startTime":"0","endTime":"0","summary":"Co-Diagnostics ships Vector Smart mosquito surveillance equipment to overseas US Air Force baseCo-Diagnostics shipped Vector Smart mosquito surveillance laboratory equipment, consumables, reagents, an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL49sBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664785948","title":"Lakeland Fire + Safety to Attend September Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664785948","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664785948?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:32","pubTimestamp":1788265976,"startTime":"0","endTime":"0","summary":"Lakeland Fire + Safety to attend September investor conferencesLakeland will attend the Lake Street Capital Markets BIG10 investor conference on Sept. 10, 2026 in New York.Management will also attend ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4lzHHJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","LAKE","SG9999014013.SGD","IE00B66KJ199.SGD","BK4568","BK4588","IE00B19Z4B17.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","IE0031619046.USD","LU0314104364.USD","SG9999014039.USD","IE00BKPKM429.USD","IE00B7SZL793.SGD","BK4112","SG9999014005.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","NDAQ","LU2095319765.USD","IE00B64PRP62.GBP","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","BK4202","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","IE000MB6IJN5.SGD","LU2324357040.USD","LU2106854487.HKD","LU1201861249.SGD","LU2237438978.USD","LU0097036916.USD","SG9999001176.USD","LU0225284248.USD","LU0289739343.SGD","LU1979441026.SGD","SG9999002224.SGD","LU2456880835.USD","LU2023251221.USD","688235","IE00B19Z3B42.SGD","LU0889565916.HKD","LU0225771236.USD","LU0162691827.USD","LU2756315664.SGD","LU0823434583.USD","GSKH","SGXZ99366536.SGD","LU0820561909.HKD","LU2111349929.HKD","LU0006306889.USD","IE0002141913.USD","SG9999015945.SGD","LU2491050154.USD","VHT","AZNH","LU0861579265.USD","LU1196500208.SGD","IE00BVYPNW00.USD","LU1043141396.HKD","JDOC","04332","LU0289961442.SGD","LU0942090050.USD","LU1037948541.HKD","LU0174119429.USD","FTXH","LU0985320562.USD","NVO","SG9999015341.SGD","IE0001KFT4U8.USD","TMED","LU0545039389.USD","LU2361044949.HKD","IXJ","LU1280957306.USD","LU1914381329.SGD","IE00BFSS8Q28.SGD","LU1059921491.USD","LU1145028129.USD","LU1244550577.SGD","LU0310800379.SGD","LU0061475181.USD","LU0417517546.SGD","TBXU","FHLC","LU0661504455.SGD","LU1720051108.HKD","SG9999018857.SGD","BK0239","LU1923622614.USD","LU1778281490.HKD","LU1127390331.HKD","PJP","LU1868836591.USD","LU1718418525.SGD","LU0792757196.USD","IE00BJJMRX11.SGD","IYH","LU1934455194.USD","XLV","CURE","BK4505","LU0203201768.USD","BMY","IE00BJLML261.HKD","LU0210536198.USD","LU2592432038.USD","LU0823416689.USD","IE000BZT7R73.USD","LU2242652126.USD","SG9999015358.SGD","IE0000B7K699.USD","LU0456855351.SGD","LU1974910355.USD","LU0648001328.SGD","LU0203347892.USD","MEDX","IE00BK4W5L77.USD","LU0158827948.USD","LU0053666078.USD","LU2213496289.HKD","LU2491050071.SGD","BK4007","LU1267930813.SGD","LU0511384066.AUD","PAWZ","IE00BDGV0183.EUR","SGXZ57979304.SGD","LU1983299246.USD","SG9999014898.SGD","GB00BDT5M118.USD","LU0353189763.USD","LU1548497426.USD","ELIS","LU1267930490.SGD","LU1585245621.USD","LU1496350502.SGD","PFE","NVOH","IE00B19Z3581.USD","AZN","LU0203202063.USD","LU1035775433.USD","IE00B1BXHZ80.USD","LU2487616109.SGD","LU1232071149.USD","IE00B3PB1722.GBP","LU1804176565.USD","LU0321505439.SGD","BK4585","LU1074936037.SGD","LU2430703178.SGD","LU0114720955.EUR","BK4581","LU0096364046.USD","LU2237443465.HKD","LU2168564222.USD","IE00BKDWB100.SGD","BBIO","BK4534","LU2237443382.USD","BK4583","LU2063271972.USD","IE00BFTCPJ56.SGD","GILD","BK4550","LU0128525929.USD","LU0124676726.USD","LU2750360641.GBP","LU0708994859.HKD","LU1868837300.USD","LU2746668974.SGD","LU2462157665.USD","IBBQ","SG9999017495.SGD","LU1221951129.SGD","LU0225283273.USD","LU0320765489.SGD","LU0949170772.SGD","LU2023250504.SGD","LU2461242641.AUD","LU2430703095.HKD","LU0109394709.USD","LU0154236417.USD","LU1366192091.USD","IE00BFSS7M15.SGD","LU2357627491.SGD","AGNG","LU1929549753.HKD","LU0234570918.USD","LU0795875169.SGD","LU2362541513.USD","LU2129689605.HKD","IE0004445239.USD","SG9999014542.SGD","LU2236285917.USD","LU0553294199.USD","LU1989772840.SGD","LU0683600562.USD","LU2089284900.SGD","IE00BZ1G4Q59.USD","LU0354030438.USD","LU0477156953.USD","LU2087625088.SGD","IE00BVYPNV92.GBP","LU1732799900.SGD","LU0882574055.USD","JNJ","LU0320765059.SGD","GLAM","LU0795875086.SGD","LU0122379950.USD","SG9999018865.SGD","LU1267930730.SGD","IE00B4R5TH58.HKD","LU2462591350.SGD","SG9999014880.SGD","LLY","IE00BWXC8680.SGD","LU2417539215.USD","LU0787776722.HKD","LU0980610538.SGD","LU1883839398.USD","SGXZ81514606.USD","LU0345769631.USD","IE0005OL40V9.USD","LU0130102774.USD","LU0265550359.USD","LU2237443978.SGD","LU0109391861.USD","LU0432979614.USD","ONC","LU1720051017.SGD","LU0058720904.USD","LU0158827781.USD","SG9999001440.SGD","LU2347655156.SGD","LU0738911758.USD","SG9999014559.SGD","LU1066051498.USD","LU2237443622.USD","LU0170899867.USD","LU1267930573.SGD","LU1934455863.HKD","GDOC","LU1236620750.USD","LU0943347566.SGD","LU1093756168.USD","LU1496350171.SGD","LU0130517989.USD","LU1868836914.USD","LU0069063385.USD","LU1323610961.USD","LLYZ","LLII","LU1712237335.SGD","LU1670628061.USD","LU0708995401.HKD","MEDI","LU0640476718.USD","LU2471134952.CNY","LU1244550494.USD","IE00BK4W5M84.HKD","IE00BFXG1179.USD","LU2403377893.USD","IE00BSNM7G36.USD","OZEM","IE00B4JS1V06.HKD","BK4559","LU0689626769.HKD","LU0965509283.SGD","LU1061106388.HKD","BK7067","LU1571399168.USD","LU1093756325.SGD","LU0726765562.USD","LU2750360997.AUD","SG9999001176.SGD","LU0238689110.USD","LLYX","LU1236620834.HKD","LU2125909247.SGD","ELIL","LU2361045086.USD","LU0072461881.USD","IE0009355771.USD","LU0395794307.EUR","LU1032955483.USD","SGXZ51526630.SGD","LU2089283258.USD","IE00B7KXQ091.USD","LU0323591593.USD","LU2471134523.USD","LU2347655073.USD","LU0471298694.HKD","LU1894683264.USD","LU1917777945.USD","LU1670711040.USD","LU0237698245.USD","LU2125154778.USD","LU0345770308.USD","LU1069344957.HKD","NVOX","SGXZ31699556.SGD","LU1261432733.SGD","LU1691799644.USD","BK4504","LU0426412945.USD","LU0823434740.USD","IE0034235303.USD","LU0256863811.USD","LU2471134879.HKD","LU2357305700.SGD","LU0868494708.USD","BIB","LU0965508806.USD","LU1551013425.SGD","LU0320765646.SGD","IE0002270589.USD","RXL","LU1116320737.USD","IE00BLSP4452.SGD","LU2168564149.EUR","NVOC","SG9999015978.USD","LU2430703251.USD","LU1066051811.HKD","IHE","LU0098860793.USD","IE00BGHQF631.EUR","TRUH","LU0256863902.USD","IE00BJJMRZ35.SGD","LU0985481810.HKD","LU1121112475.USD","LU0472753341.HKD","IE00BJJMRY28.SGD","LU1670711123.USD","GSK","LU1829250122.USD","LU1228905037.USD","LU1066053197.SGD","LU2242646821.SGD","LU1023059063.AUD","LU2089984988.USD","BK4516","LU0786609619.USD","LU0310799852.SGD","IE00BKPKM429.USD","THNR","IE000F7OJYX1.SGD","LU0267386448.USD","LU2237443895.HKD","LU0203345920.USD","LU2468319806.SGD","LU0070217475.USD","LU2746668461.USD","LU0265550946.USD","BBH","LU1162221912.USD","LU2552382058.USD","LU0316494557.USD","LU2108987350.USD","LU0133085943.USD","LU2028103732.USD","LU2237443549.SGD","SG9999014567.USD","ABBV","LU1988902786.USD","LU0057025933.USD","LU1623119135.USD","LU0320765992.SGD","LU0306807586.USD","LU1674673691.USD","IE00B775H168.HKD","LU2433249047.HKD","LU0210528500.USD","IE000SO60NU8.SGD","WDNA","LU0672654240.SGD","LU0353189680.USD","LU2491049909.HKD","LU0994945656.USD","IE00B42XCP33.USD","LU1629891620.HKD","LU1868837136.USD","LU0689472784.USD","LU1839511570.USD","SG9999013999.USD","NVS","LU0345770993.USD","LU1814569148.SGD","LU0882574139.USD","LU1941712264.USD","MHIP","IE00BN8TJ469.HKD","LU0211328371.USD","IE00BBT3K403.USD","LU0198837287.USD","LU0385154629.USD","LU2271345857.HKD","LU1066051225.USD","GSK.UK","IE0004445015.USD","LU1037948897.HKD","IBB","IE00BLSP4239.USD","LU0466842654.USD","LU2596442595.SGD","PBE","IE00BKVL7J92.USD","IE00B1XK9C88.USD","LU2602419157.SGD","IE00BJT1NW94.SGD","LU1670710661.SGD","LU1674673428.USD","LU0912757837.SGD","SG9999002232.USD","LU0211327993.USD","LU2133065610.SGD","LU2112291526.USD","LU0208291251.USD","LU0070302665.USD","LU2896262040.SGD","LU1069347547.HKD","LU0079474960.USD","LU0820562030.AUD","LU0545562505.USD","CANC","LU1430594728.SGD","LU2125909593.SGD","PPH","LU2505996509.AUD","AMGN","LU2125154935.USD","LU0266013472.USD","MRK","SG9999015952.SGD","LU0889566641.SGD","LU0029864427.USD","LU2471134796.USD","SG9999014906.USD","HRTS","LU2362540622.SGD","LU1732800096.USD","LU0306806265.USD","BMED","LU0354030511.USD","LU1934455277.USD","LU1032466523.USD","LU0965509101.SGD","LU1670710588.SGD","LU2211815571.USD","LU1894683348.USD","LU0106261372.USD","LU1935042991.SGD","BK7501","LU0964807845.USD","LU0426417589.USD","BK4578","LU1670627923.USD","LU1868836757.USD","LU1551013342.USD","SG9999014575.USD","IE00B2B36J28.USD","06160","ILDR","LU1064131342.USD","LU2756315318.SGD","LU1116320901.HKD","LU2360032135.SGD","SG9999011175.SGD","SGXZ80539844.SGD","LU0471298777.SGD","LU2168564495.EUR","BK4533","BK7511","LU0859254822.USD","LU2361044865.SGD","LU2265009873.SGD","LU0211331839.USD","LU1228905540.USD","BK4568","LU2023250330.USD","LU2552382215.SGD","LU2264538146.SGD","LU2552382132.HKD","LU1941712348.USD","CSL.AU","LU1003077747.HKD","LU1244550221.USD","LU2129689431.USD","IE00B3T34201.USD","LU1057294990.SGD","SG9999014914.USD","LU1043141123.HKD","SG9999015986.USD","LU1035773651.USD","IE000WAW04H5.SGD","LU1699723380.USD","BK4592","LU0868494617.USD","BK4139","LU0234572021.USD","LU1506573853.SGD","REGN","SG9999003800.SGD","LU2362541273.HKD","LU0345769128.USD","BK4588","IE00BN29S564.USD","LU1989772923.USD","LU2505996681.GBP","LU1291159041.SGD","IE00B7SZLL34.SGD","LU2087621335.USD","LU1989771016.USD","IE000M9KFDE8.USD","LU0321505868.SGD","LU1221951046.USD","LU2023250843.SGD","LU2168563687.JPY","BK4532","BK7508","LU2168564065.EUR","BK4566","BK4599","LU0820561818.USD","LU2129689514.USD","LU0094547139.USD","LU2360106947.USD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664408855","title":"Ocugen Doses First Patient in Trial of Potential Eye Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664408855","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664408855?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:35","pubTimestamp":1788262505,"startTime":"0","endTime":"0","summary":"Ocugen Inc  has dosed its first patient in a phase 3 trial of its OCU410 modifier gene therapy as a potential treatment for geographic atrophy secondary to dry age-related macular degeneration, the company said Tuesday.The drug is designed as a one-time subretinal gene therapy, the company said.The placebo-controlled study has enrolled 237 patients, the company said.The company plans to file a biologics license application for the therapy in 2028, it said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4563","BK4568","BK4139","OCGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664555058","title":"AstraZeneca completes global license agreement for Zegfrovy in lung cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664555058","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664555058?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:10","pubTimestamp":1788261040,"startTime":"0","endTime":"0","summary":"AstraZeneca (AZN) announced the completion of the exclusive license agreement with Dizal Pharmaceutical for Zegfrovy – sunvozertinib -, an oral irr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-completes-global-license-agreement-for-zegfrovy-in-lung-cancer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-completes-global-license-agreement-for-zegfrovy-in-lung-cancer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","LU2417539215.USD","LU0058720904.USD","LU2456880835.USD","BK4585","LU0289739699.SGD","LU1267930573.SGD","LU2237443978.SGD","BK4568","LU2237443895.HKD","IE00B3T34201.USD","LU2468319806.SGD","LU2237443382.USD","LU0109394709.USD","LU0889565916.HKD","LU2237443465.HKD","LU2462157665.USD","BK4588","LU0320765992.SGD","LU2089984988.USD","AZNH","LU0432979614.USD","LU0029864427.USD","LU2237443622.USD","LU0310800379.SGD","LU2236285917.USD","BK4007","LU0708994859.HKD","LU1829250122.USD","AZN","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853292","title":"Ocugen - Bla Filing for Ocu410 Anticipated in 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853292?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:02","pubTimestamp":1788260520,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA1R23YC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","OCGN","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664185321","title":"Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of Ocu410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration","url":"https://stock-news.laohu8.com/highlight/detail?id=2664185321","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664185321?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:02","pubTimestamp":1788260520,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA1R23YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","OCGN","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664830033","title":"Aethlon Medical Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2664830033","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664830033?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:06","pubTimestamp":1788257173,"startTime":"0","endTime":"0","summary":"Aethlon Medical announces annual shareholder meetingAethlon Medical will hold its annual shareholder meeting virtually on Oct. 1, 2026.Shareholders will vote on electing five directors, ratifying audi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4Y3hLN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4082","BK4568","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664322228","title":"AstraZeneca Reports 'Meaningful Improvement' in Phase 3 Study of Lung Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2664322228","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664322228?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:01","pubTimestamp":1788253304,"startTime":"0","endTime":"0","summary":"AstraZeneca  said early Tuesday that Tagrisso plus Orpathys in a phase 3 trial showed a \"statistically significant and highly clinically meaningful improvement\" in progression-free survival versus tagrisso alone in a trial of newly diagnosed lung cancer patients.The SANOVO Phase 3 trial included 326 patients in China who had not previously been treated for advanced lung cancer with specific genetic changes, according to AstraZeneca.The benefit was seen in both the high MET and intention-to-treat trial populations, the company said. The combination also showed what the company described as very encouraging clinical benefit in overall survival, which is a secondary endpoint, although the trial will continue to follow patients.The safety profile for Tagrisso plus Orpathys was consistent with the known profiles of each medicine, and no new safety findings emerged.The results from the trial reinforce tagrisso as the backbone therapy across epidermal growth factor receptor-mutated lung cance","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2456880835.USD","LU2237443895.HKD","LU0058720904.USD","LU2237443622.USD","LU0310800379.SGD","LU0432979614.USD","LU0889565916.HKD","LU2236285917.USD","LU0289739699.SGD","BK4588","BK4585","BK4007","LU2237443465.HKD","LU2237443382.USD","LU1829250122.USD","LU0320765992.SGD","BK4568","AZN","LU2089984988.USD","LU0708994859.HKD","IE00B3T34201.USD","LU0029864427.USD","LU2237443978.SGD","LU0109394709.USD","LU1267930573.SGD","LU0128525929.USD","LU2237443549.SGD","AZNH","LU2417539215.USD","LU2468319806.SGD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664739831","title":"AstraZeneca Says Breast Cancer Combo Approved in EU; Completes Acquisition of License for Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2664739831","media":"MT Newswires Live","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664739831?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:58","pubTimestamp":1788249536,"startTime":"0","endTime":"0","summary":"AstraZeneca  and Daiichi Sankyo's combination of Enhertu plus pertuzumab has been approved in the European Union as a first-line treatment of patients with HER2-positive metastatic breast cancer, the companies said Tuesday.The approval triggers a $100 million milestone payment by AstraZeneca to Daiichi Sankyo. It was based on a phase 3 study that showed the drug combination reduced the risk of disease progression or death by 44% compared with the standard of care.Astrazeneca also said it has completed its previously announced worldwide exclusive license agreement with Dizal Pharamceutical for Zegfrovy, a treatment for patients with lung cancer.The company will make an upfront payment of $600 million to Dizal, along with additional payments of up to $900 million on achievement of specific development.Under the deal, Dizal will also receive royalties on sales of Zegfrovy, the company said.The payout does not impact AstraZeneca's 2026 financial guidance, it added.AstraZeneca shares were d","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0058720904.USD","AZNH","LU1267930573.SGD","LU2237443465.HKD","LU2237443895.HKD","LU2237443382.USD","BK4568","LU0109394709.USD","LU0889565916.HKD","LU0029864427.USD","BK4588","LU2237443549.SGD","LU0320765992.SGD","LU2089984988.USD","LU2417539215.USD","BK4007","LU2468319806.SGD","LU2237443978.SGD","AZN","LU0128525929.USD","LU2236285917.USD","LU0432979614.USD","LU0708994859.HKD","BK4585","LU2456880835.USD","IE00B3T34201.USD","LU1829250122.USD","LU2462157665.USD","LU2237443622.USD","LU0289739699.SGD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664836115","title":"Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664836115","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664836115?lang=en_us&edition=fundamental","pubTime":"2026-09-01 14:51","pubTimestamp":1788245470,"startTime":"0","endTime":"0","summary":"TradingKey - In August 2026, the upward momentum in US stocks broadened significantly. Moderna (MRNA) topped the S&P 500 constituents with a 156% gain, surging 375.9% year-to-date. Palantir (PLTR) followed closely behind, rising 51.5% in August, while enterprise software stocks as a whole extended their previous recovery.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230915/5159981a89101d628f3e4c33ac20272e.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230915/5159981a89101d628f3e4c33ac20272e.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262143172-top-10-best-performing-us-stocks-august-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BK4613","LU0345780950.USD","MRNA","PTIR","LU2028103732.USD","LU2517655028.SGD","LU1720051108.HKD","LU1223083913.SGD","LU2756315664.SGD","LU0154245673.USD","LU0130102774.USD","LU0640476718.USD","SMCL","IE00B19Z9Z06.USD","SMCI","COWG","BK4607","LU0053671581.USD","PLTR","CNAV","LU1951198990.SGD","EYES","PLTL","LU0127658192.USD","NWMX","PLYY","LU1267930813.SGD","BK4139","SNDG","BK4527","SCHA","LU2265009873.SGD","PLTA","LU0612318385.USD","LU1989764664.SGD","PTF","LU0265550359.USD","LU0511384066.AUD","LU1923622291.USD","LU2461242641.AUD","LU0823434740.USD","SPLTRmain","LU1989772923.USD","LU0082616367.USD","LU0792757196.USD","LU1223082519.USD","SMCZ","LU0048573561.USD","SHLD","LU0980610538.SGD","LU1988902786.USD","IE00BJTD4V19.USD","BK4528","BK4023","LU0289961442.SGD","LU1267930227.SGD","SNDC","LU1989764748.USD","BK4550","PLTW","LU0823434583.USD","LU0724618789.USD","LU2362541273.HKD","AIPI","LU0107464264.USD","LU0198837287.USD","IE00B19Z8X17.USD","LU0630314457.HKD","PLTU","LU0353189763.USD","LU0472753341.HKD","LU0496367417.USD","SMCC","LU0124676726.USD","LU1551013425.SGD","LU0265550946.USD","LU0353189680.USD","IE00BJTD4N35.SGD","LU1316542783.SGD","LU2290526834.HKD","LU0310799852.SGD","LU0058720904.USD","LU1064131342.USD","BK4585","IE00BMPRXR70.SGD","BK4534","LU2125909247.SGD","QQQG","LU2433249047.HKD","EKG","LU1223082196.USD","BK4538","LU0708995401.HKD","GNOM","CLOD","LU2458330169.SGD","NOWX","LU0320765059.SGD","TRUM","LU0006306889.USD","LU2517655291.USD","LU2125909759.SGD","LU1116320737.USD","FCUS","LU0158827948.USD","LU0187121727.USD","LU0330918003.SGD","LU0648001328.SGD","DISK","LU0128525689.USD","LU0477156797.USD","LU2023251221.USD","LU1023059493.AUD","PLTD","LU0788109121.HKD","LU2357305700.SGD","LU1923623000.USD","TMSL","BK4579","LU0158827781.USD","SG9999001143.SGD","LU0348723411.USD","LU2125909593.SGD","LU0130103400.USD","LU0820561909.HKD","LU0612318971.USD","LU2381873111.SGD","LU0314104364.USD","LU2106854487.HKD","LU0498741890.SGD","LU2089284900.SGD","LU2458330243.SGD","LU1046421795.USD","IE00BZ9MQY76.HKD","LU0689472784.USD","LU1201861249.SGD","LU0788108826.HKD","LU2125909916.SGD","LU2462611646.USD","LU0345781412.USD","LU0130517989.USD","LU0477156953.USD","LU0267386448.USD","LU1923622614.USD","LU1280957306.USD","LU1366333091.USD","BK4503","AGMI","IE00BQXX3C00.GBP","LU0354030511.USD","OPTZ","AUAU","LU0345780521.USD","LU1951200564.SGD","LU1720051017.SGD","LU0081259029.USD","LU0642271901.SGD","BK4570","IE00BKVL7J92.USD","LU1267930730.SGD","BK4581","LU2244417387.USD","LU2023250843.SGD","LU0211327993.USD","LU0266512473.USD","LU1548497426.USD","SMCX","LU0251131958.USD","BK4598","LU0106261372.USD","LU0170899867.USD","LU0354030438.USD","SNDK","LU0528227936.USD","LU0820562030.AUD","LU1791710582.SGD","LU0648000940.SGD","LU2498475776.HKD","LU0719512351.SGD","LU2111349929.HKD","IE00B19Z9P08.USD","SLVP","PSKY","SMYY","LU1814569148.SGD","BK4533","LU1791710400.SGD","SNXX","LU0456854461.SGD","LU1803068979.SGD","BK4548","IE00B19Z9505.USD","FSMD","BK4167","LU1823568750.SGD","LU0498741114.HKD","LU0889566641.SGD","LU1861558580.USD","LU0266013472.USD","LU0234570918.USD","LU0316494557.USD","BK4017","LU0368265764.SGD","LU2756315318.SGD","LU2543165471.USD","VEEV","LU0300736062.USD","IE0002270589.USD","MRNX","LU1496350502.SGD","BK4566","LU1551013342.USD","LU0289739699.SGD","SNDU","IDNA","BK4608","LU1861559042.SGD","LU2087625088.SGD","LU2264538146.SGD","LU0278409577.USD","LU0300736492.USD","BK4097","BK4567","LU2361045086.USD","LU2271345857.HKD","LU2360107168.USD","NEM","LU2089283258.USD","LU1323610961.USD","LU1430597077.USD","LU0943347566.SGD","LU0054578231.USD","LU1974910355.USD","LU1267930490.SGD","BK4551","LU2361044865.SGD","LU0889565833.HKD","LU0057025933.USD","SGDM","LU0130518102.USD","SNDQ","PLTG","LU0310800965.SGD","MRNY","LU2362541513.USD","LU0238689110.USD","LU1116320901.HKD","LU0055631609.USD","LU0820561818.USD","IE00B19Z3B42.SGD","LU0289739343.SGD","BK4134","SCHM","LGHT","IT","LU2362540622.SGD","LU1883866441.USD","LU1917777945.USD","BK4505","LU2361044949.HKD","LU2063271972.USD","LU0154245756.USD","LU0654597011.USD","LU0211328371.USD","LU0069063385.USD","IE00B19Z3581.USD","LU0689626769.HKD","PLTZ","NOWL","IE00BMPRXN33.USD","LU1861220033.SGD","LU1989772840.SGD","LU2247934214.USD","GUNZ","LU1235294995.USD","LU0345780281.USD","LU2286300806.USD","BK4125","LU2517655374.HKD","PLT","LU0672654240.SGD","PLOO","BK4535","GDX","NEMG","PLTY","BK4504","BK4568","LU0157215616.USD","PLTI","CRMG","LU2236285917.USD","BK4588","LU0109391861.USD","SMCY","LU0075056555.USD","LU1804176565.USD","LU0266512127.USD","CRM","LU0109392836.USD","IE00BZ1G4Q59.USD","FMTL","LU0052756011.USD","LU0963586101.USD","LU0557290698.USD","BK4543","LU1201861165.SGD","LU1861215975.USD","IE00BQXX3D17.EUR","LU1496350171.SGD","IGV","LU1153585028.USD","NOW","LU0742534661.SGD","LU0234572021.USD","LU2023250504.SGD","BK4532","BK4501","IE00B19Z8W00.USD","BK4561","IE00B894F039.SGD","WDNA","GDMN","LU0011850046.USD","BK4547","LU0251142724.SGD","BK4170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897568","title":"American Tungsten & Antimony Taps Finland Firm for Scoping Study; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897568","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897568?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:28","pubTimestamp":1788222490,"startTime":"0","endTime":"0","summary":"American Tungsten & Antimony  engaged Metso Finland to complete a front-end loading stage one scoping study for an ammonium paratungstate  production circuit at the Del Sol Refinery in Nevada, according to a Tuesday filing with the Australian bourse.The study will assess an APT circuit within the permitted facility as an alternative to a standalone greenfield tungsten processing plant, the filing said.The refinery is the subject of the share sale and purchase agreement disclosed by the company in July.The acquisition has not yet completed, per the filing.American Tungsten & Antimony shares rose 4% in morning trade Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4117","BK4107","AT4.AU","AFG","BK7095","BK4086","BK4568","APT","APT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881857","title":"Did Targeted XFG COVID Shots Just Recenter Pfizer's (PFE) Post‑Pandemic Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881857","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881857?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:16","pubTimestamp":1788218161,"startTime":"0","endTime":"0","summary":"Pfizer and BioNTech previously received FDA approval for their 2026–2027 COMIRNATY XFG mRNA COVID-19 vaccine, tailored to the XFG variant, for adults 65+ and high-risk individuals aged 5–64, with U.S. distribution beginning shortly after approval.\nThis targeted approval keeps Pfizer’s mRNA platform actively in use for high‑risk populations and aligns the company’s vaccine portfolio with the FDA’s latest variant-composition guidance.\nWe’ll now examine how ongoing XFG-variant vaccine shipments...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/did-targeted-xfg-covid-shots-just-recenter-pfizers-pfe-postp","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/did-targeted-xfg-covid-shots-just-recenter-pfizers-pfe-postp","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0321505439.SGD","LU1883839398.USD","BK4533","LU1066051498.USD","IE00BLSP4239.USD","PFE","SG9999001176.SGD","LU0058720904.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0868494617.USD","IE00BBT3K403.USD","BK4568","LU0289739699.SGD","IE00BLSP4452.SGD","LU0122379950.USD","LU0306806265.USD","SG9999003800.SGD","SG9999011175.SGD","LU0306807586.USD","LU1057294990.SGD","LU1894683264.USD","LU0170899867.USD","LU0225284248.USD","LU0456855351.SGD","LU0985481810.HKD","BK4550","BK4007","IE00B19Z3581.USD","LU1023059063.AUD","SG9999002224.SGD","BK4588","LU1066053197.SGD","BK4534","LU0225771236.USD","SG9999001176.USD","SGXZ57979304.SGD","BK4592","SG9999002232.USD","LU0321505868.SGD","BK4599","IE000M9KFDE8.USD","BK4585","IE00B3T34201.USD","LU1894683348.USD","LU2596442595.SGD","OZEM","BK4581","LU0234572021.USD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664988558","title":"Novavax Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2664988558","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664988558?lang=en_us&edition=fundamental","pubTime":"2026-09-01 05:28","pubTimestamp":1788211680,"startTime":"0","endTime":"0","summary":"DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  advanced 1.19% to $9.37 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.12% to 26,370.89 and Dow Jones Industrial Average  falling 0.70% to 53,185.90.This was the stock's second consecutive day of gains.Novavax Inc. closed 21.72% below its 52-week high of $11.97, which the company achieved on February 26th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  fell 0.82% to $265.85, Pfizer Inc.  rose 1.79% to $28.46, and Merck & Co. Inc.  fell 0.40% to $147.76.Trading volume  eclipsed its 50-day average volume of 4.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 31, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4547","BK4585","BK4588","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664398885","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664398885","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664398885?lang=en_us&edition=fundamental","pubTime":"2026-09-01 05:25","pubTimestamp":1788211500,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  shed 1.55% to $1.27 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.12% to 26,370.89 and Dow Jones Industrial Average  falling 0.70% to 53,185.90.Inovio Pharmaceuticals Inc. closed 57.37% short of its 52-week high of $2.98, which the company reached on September 9th.The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson  fell 0.82% to $265.85, Statera Biopharma Inc.  rose 100.00% to $0.00, and Pfizer Inc.  rose 1.79% to $28.46.Trading volume  eclipsed its 50-day average volume of 3.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 31, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4583","INO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":8,"totalSize":213,"code":"91000000","status":"200"}]}}